Skip to main content
Have a personal or library account? Click to login
Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology Cover

Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology

Acta Pharmaceutica
Volume 59 (2009): Issue 1 (March 2009)
By: ,   and    
Open Access
|Mar 2009
References

References

  1. H. W. Hui, J. R. Robinson and V. H. L. Lee,, in(V. H. L. Lee), 2ed., Marcel Dekker, New York 1987, pp. 373-374.
    Open DOISearch in Google Scholar
  2. R. K. Verma, B. Mishra and S. Garg, Osmotically controlled oral drug delivery,(2000) 695-708; DOI: 10.1081/DDC-100101287.
    Open DOISearch in Google Scholar
  3. M. Speers and C. Bonnano,, in(Ed. E. Mathiowitz), Wiley, New York 1999, pp. 341-347.
    Search in Google Scholar
  4. R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems,(2002) 7-27; DOI: 10.1016/j.conrel.2003.09.009.
    Search in Google Scholar
  5. F. Theeuwes, Elementary osmotic pump,(1975) 1987-1991; DOI: 10.1002/jps. 2600641218.
    Search in Google Scholar
  6. P. Kumar, S. Singh, P. S. Rajinikanth and B. Mishra, An overview of osmotic pressure controlled release formulation,(2006) 34-45.
    Search in Google Scholar
  7. P. Kumar and B. Mishra, An overview of recent patents on oral osmotic drug delivery systems,(2007) 236-255; DOI: 10.2174/187221107782331638.
    Open DOISearch in Google Scholar
  8. S. A. Schug, Tramadol in acute pain,(2003) 1-3; DOI: 10.1016/S1366-0071(03) 00028-7.
    Search in Google Scholar
  9. C. Mattia and F. Coluzzi, Once-daily tramadol in rheumatological pain,(2006) 1811-1815; DOI: 10.1517/14656566.7.13.1811.
    Open DOISearch in Google Scholar
  10. S. B. Tiwari, K. Murthy, M. R. Pai, P. R. Mehta and P. S. Choudhary, Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system,(2003) 1-6.
    Search in Google Scholar
  11. P. Kumar, S. Singh and B. Mishra, Gastroretentive drug delivery system of ranitidine hydrochloride based on osmotic technology: development and evaluation,(2008) 332-342; DOI: 10.2174/156720108785914943.
    Open DOISearch in Google Scholar
  12. J. Shokri, P. Ahmedi, P. Rashidi, M. Shahsavri, A. R. Siahboomi and A. Nokhodchi, Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water soluble drugs,(2008) 289-297; DOI: 10.1016/j.ejpb.200706.006.
    Search in Google Scholar
  13. 30,vol. 1, USP Convention, Rockville 2007.
    Search in Google Scholar
  14. C. Aguzzi, M. C. Bonferoni, M. R. Osorio, F. S. Rossi, F. Ferrari and C. Caramella, Influence of complex solubility on formulations based on lambda carrageenan and basic drugs,(2002) 1-7.
    Search in Google Scholar
  15. M. R. Rouini, Y. H. Ardakani, F. Soltani, H. Y. Aboul-Enein and A. Foroumadi, Development and validation of rapid HPLC method for simultaneous determination of tramadol and its metabolites in human plasma,(2006) 207-211; DOI: 10.1016/j.jchromb.2005.10.039.
    Open DOISearch in Google Scholar
  16. A. Kucuk, Y. Kadioglu and F. Celebi, Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction,(2005) 203-208; DOI: 10.1016/j.jchromb. 2004.11.031.
    Search in Google Scholar
  17. P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles,(2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
    Open DOISearch in Google Scholar
  18. B. Mishra, B. V. Bakde, P. N. Singh and P. Kumar, Development and in-vitro evaluation of oral sustained release formulation of tramadol hydrochloride,(2006) 153-166.
    Search in Google Scholar
  19. X. Li, W. Pan, S. Nie and L. Wu, Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe,(2004) 359-367; DOI: 10.1016/j/jconrel.2004.01.026.
    Search in Google Scholar
  20. N. Sinchaipanid, S. Pongwai, P. Limsuwan and A. Mitrevej, Design of salbutamol EOP tablets from pharmacokinetic parameters,(2003) 135-142; DOI: 10.1081/PDT-120018479.
    Open DOISearch in Google Scholar
  21. F. Musshoff and B. Madea, Fatality due to ingestion of tramadol alone,(2001) 197-199; DOI: 10.1016/s0379-0738(00)00374-1.
    Open DOISearch in Google Scholar
  22. A. M. Razaghi and J. B. Schwartz, Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water swellable polymer,(2002) 631-639; DOI: 10.1018.DDC-120003855.
    Open DOISearch in Google Scholar
  23. A. M. Razaghi and J. B. Schwartz, Release of cyclobenzaprine hydrochloride from osmotically rupturable tablets,(2002) 695-701; DOI: 10.1081/DDC-120003861.
    Open DOISearch in Google Scholar
  24. ICH Q1A (R2),, EMEA, London 2003.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10007-009-0010-2 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian
Page range: 15 - 30
Published on: Mar 20, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
tramadol,
extended release,
osmotic pressure,
swellable polymer,
in vitro-in vivo correlation
Related subjects:
Pharmacy,
Pharmacy, other

© 2009 Pramod Kumar, Sanjay Singh, Brahmeshwar Mishra, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 59 (2009): Issue 1 (March 2009)
Previous article
Next article